RRM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.606400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.273200E-01
Normal-vs-Stage2
3.022200E-01
Normal-vs-Stage3
6.971800E-01
Normal-vs-Stage4
6.373800E-01
Stage1-vs-Stage2
6.972800E-01
Stage1-vs-Stage3
7.620200E-01
Stage1-vs-Stage4
8.143200E-01
Stage2-vs-Stage3
4.315600E-01
Stage2-vs-Stage4
4.935000E-01
Stage3-vs-Stage4
9.128000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.669800E-01
Normal-vs-AfricanAmerican
6.078800E-01
Normal-vs-Asian
2.114200E-01
Caucasian-vs-AfricanAmerican
5.401200E-01
Caucasian-vs-Asian
3.225000E-01
AfricanAmerican-vs-Asian
2.519600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.130400E-01
Normal-vs-Female
3.126200E-01
Male-vs-Female
3.055000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.624400E-01
Normal-vs-Age(41-60Yrs)
3.346000E-01
Normal-vs-Age(61-80Yrs)
3.748200E-01
Normal-vs-Age(81-100Yrs)
2.988600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.603400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.668400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.300800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.189600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.495600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.660800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.113000E-01
Normal-vs-Daily Drinker
3.603200E-01
Normal-vs-Weekly Drinker
4.016200E-01
Normal-vs-Occasional Drinker
3.395000E-01
Normal-vs-Social Drinker
4.754200E-01
Non Drinker-vs-Daily Drinker
7.911200E-01
Non Drinker-vs-Weekly Drinker
6.575200E-01
Non Drinker-vs-Occasional Drinker
9.288400E-01
Non Drinker-vs-Social Drinker
9.752400E-01
Daily Drinker-vs-Weekly Drinker
5.502600E-01
Daily Drinker-vs-Occasional Drinker
8.608200E-01
Daily Drinker-vs-Social Drinker
8.026600E-01
Weekly Drinker-vs-Occasional Drinker
6.166600E-01
Weekly Drinker-vs-Social Drinker
7.429800E-01
Occasional Drinker-vs-Social Drinker
9.171200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.142400E-01
Normal-vs-Grade 2
7.012600E-01
Normal-vs-Grade 3
7.411200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.159400E-03
Grade 1-vs-Grade 3
1.076900E-03
Grade 1-vs-Grade 4
6.142400E-01
Grade 2-vs-Grade 3
2.160200E-01
Grade 2-vs-Grade 4
7.012600E-01
Grade 3-vs-Grade 4
7.411200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.546000E-01
Normal-vs-NonDiabetic
3.739800E-01
Diabetic-vs-NonDiabetic
1.420620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.461400E-01
Normal-vs-NoPancreatitis
4.126600E-01
Pancreatitis-vs-NoPancreatitis
7.217600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.510800E-01
Normal-vs-N1
3.419600E-01
N0-vs-N1
6.511800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.332100E-02
Normal-vs-TP53-NonMutant
5.355800E-01
TP53-Mutant-vs-TP53-NonMutant
2.174900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
